N/A
Completed N=110
Enhanced E-cigarette Coaching Intervention for Dual Users of Cigarettes and E-cigarettes
Source: ClinicalTrials.gov NCT03575468 ↗Enrolled (actual)
110
Serious AEs
0.0%
Results posted
Sep 2022
Primary outcomePrimary: Treatment Satisfaction and Acceptability Measured on a Scale From 1-6 (Very Satisfied to Very Dissatisfied) — 5.5; 5.0 units on a scale
Summary
The purpose of this study is to develop and pilot test an enhanced behavioral coaching intervention for dual users of cigarettes and electronic nicotine delivery systems (ENDS) who call tobacco quitlines for help quitting smoking.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Treatment Satisfaction and Acceptability Measured on a Scale From 1-6 (Very Satisfied to Very Dissatisfied) |
5.5; 5.0 | — |
| PRIMARY Treatment Engagement: Call Completion |
3.4; 2.7 | — |
| SECONDARY Quit Plan Development Experience |
10.0; 9.2 | — |
| SECONDARY Knowledge and Beliefs- Relative Risk of ENDS and Cigarettes |
22; 22; 6; 5; 0; 5 | — |
| SECONDARY Knowledge and Beliefs- Relative Risk of FDA-approved Cessation Medications and Cigarettes |
25; 32; 1; 1; 1; 0 | — |
| SECONDARY Knowledge and Beliefs- Relative Risk of FDA-approved Cessation Medications and ENDS |
12; 4; 5; 9; 10; 19 | — |
Eligibility Criteria
Inclusion Criteria
- • Requested quitline coaching services and enrolled in 5 call Oklahoma Tobacco Helpline (OKHL) program
- Currently using e-cigarettes
- Indicated plan to use e-cigarettes in the next 30 days
- English Speaking
- 18+ years old
- Willing to quit cigarettes in the next 30 days
- Consented to receive automated phone outreach via the quitline (TCPA consented)
- Has an Android smartphone with an operating system of 6.0 or higher and comfort downloading and using apps on phone
- Has regular access to email
- Callback best time between the hours of 6:00 am - 3:00 pm Pacific Standard Time
Exclusion Criteria
- • Pregnant or Planning pregnancy within 3 months
- Reported Schizophrenia diagnosis history during registration
- Heart attack past 2 weeks
- Stroke/Transient Ischemic Attack past 2 weeks
- Rapid Irregular heart beat past 6 months
- Angina or heart pain past 6 months
- Currently taking Varenicline (also known as Chantix) or Bupropion (also known as Wellbutrin or Zyban)
- Previously screened for study
- Enrolled via proxy (i.e., did not self-enroll)
Data sourced from ClinicalTrials.gov (NCT03575468). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.